- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 14, 2025 | 484.65M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $485.45M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $395.31M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $201.18M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $89.63M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $636.82M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $645.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.59B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.49B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $555.97M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $442.62M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.95B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.82B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 484.32M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $11.34M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $72.59M |
| Capex | Q1 2025 · Mar 31, 2024 | $7.17M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $127.43M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.17B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.16B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.19 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $223.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | $94.39M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $132.42M |
| Revenue | Q1 2025 · Mar 31, 2024 | $748.35M |